Sponsor pipeline

CareDx clinical trial pipeline

Get alerts when CareDx's trials change

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

Notable

FORWARD · Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)

Enrolling by invitation only

CareDxNot specified NCT07607327 Registry history of NCT07607327 on ClinicalTrials.gov (opens the registry)

Oct 16, 2026

Show 1 trial with minor changes only

Minor

ACROBAT · Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test

Trial completed

Also in this update: Study completion date changed from estimate of Nov 2026 to Sep 30, 2026; Start date pushed from Jun 30, 2021 to Jul 22, 2021

CareDxNot specified NCT04635384 Registry history of NCT04635384 on ClinicalTrials.gov (opens the registry)

Oct 16, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Not charted: 5 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Acute Myeloid Leukemia (AML) (1) · Leukemia (1) · MDS/MPN Overlap (1) · Myelodysplastic Syndromes (MDS) (1)

Get alerts when CareDx's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.

Start monitoring free